Jaykay Enterprises is currently trading at Rs. 151.10, up by 3.55 points or 2.41% from its previous closing of Rs. 147.55 on the BSE.

The scrip opened at Rs. 147.50 and has touched a high and low of Rs. 153.60 and Rs. 143.65 respectively. So far 234591 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 185.00 on 10-Feb-2025 and a 52 week low of Rs. 81.25 on 23-Sep-2024.

Last one week high and low of the scrip stood at Rs. 153.60 and Rs. 143.65 respectively. The current market cap of the company is Rs. 1980.36 crore.

The promoters holding in the company stood at 62.89%, while Institutions and Non-Institutions held 0.16% and 36.96% respectively.

Jaykay Enterprises’ wholly owned subsidiary -- JK Digital & Advance Systems (JK Digital) has executed a Transfer of Technology (ToT) Agreement on September 09, 2025, with the Central Scientific Instruments Organisation (CSIO), Chandigarh - a CSIR laboratory, for the indigenous manufacturing of advanced 3D-printed lattice orthopedic implants using additive manufacturing technology.

ToT Agreement covers seven state-of-the-art orthopedic implant technologies, primarily for Spinal and Hip surgeries, including TLIF, PLIF, Buttress & Shim Augments, Shell & Wedge Augments, Lattice Cones, Cage Constructs, and Lattice Acetabular Cups. It enables domestic production of high-value implants, reducing reliance on imports and supporting the Government of India’s ‘Make in India’ initiative in the healthcare sector. It strengthens India’s medical device ecosystem with globally benchmarked, advanced technologies. 

This collaboration positions the company as one of the first Indian players to offer indigenously manufactured 3D-printed lattice medical implants at affordable costs. 

Jaykay Enterprises manufactures synthetic yarns, fibres and fabrics, portland and white cement, chemicals, fertilisers, pharmaceuticals and synthetic fibre-making machinery, and chemicals, and develops renewable energy sources.